Clinical Documents

To edit the draft, click on the text box below.

×

Draft a comprehensive differential diagnosis for acute substernal chest pain in a 45-year-old male with hypertension and hyperlipidemia, diaphoresis, exertional onset, and normal initial ECG/troponin; include life-threatening causes first, key distinguishing features, and immediate diagnostic next steps.

Draft a detailed differential diagnosis for new-onset unilateral throbbing headache with visual aura and brief monocular vision loss in a 32-year-old female on oral contraceptives; include red-flag symptoms, stroke/TIA considerations, and recommended initial workup.

Draft an assessment and plan for stage-2 hypertension (BP 162/98) in an obese 52-year-old with suspected obstructive sleep apnea; include ASCVD risk estimate, lifestyle prescriptions, first-line pharmacotherapy with drug/dose/targets, baseline labs/monitoring, and 4–6 week follow-up.

Draft an assessment and plan for type 2 diabetes follow-up with A1c 9.2% on metformin 1,000 mg BID and eGFR 65; compare adding a GLP-1 receptor agonist vs an SGLT2 inhibitor, address weight loss goals, hypoglycemia education, vaccinations, and micro/macrovascular screening.

Draft a history and physical for a patient presenting with chest pain, including HPI using OLDCARTS, pertinent ROS, PMH/meds/allergies, FH/SH, focused cardiac/pulmonary exam, initial labs and imaging orders, prioritized differential, HEART score risk stratification, and early management.

Draft a history and physical for a new patient with progressive exertional dyspnea, orthopnea, and bilateral leg edema; include differential (heart failure, COPD, PE, anemia, renal disease), targeted exam maneuvers, and first-line diagnostics and management.

Draft a progress note for COPD follow-up two weeks after an acute exacerbation treated with prednisone and antibiotics; include symptom trajectory, CAT score (if available), inhaler technique/adherence, oxygen needs, spirometry plan, smoking cessation counseling, and return precautions.

Draft a progress note for post-operative day 2 after total knee arthroplasty; include pain control strategy, DVT prophylaxis, PT/OT milestones, wound status, bowel/urinary function, labs/vitals review, complications screening, and discharge readiness.

Draft a discharge summary for community-acquired pneumonia admission; include admission/discharge dates, presenting symptoms, radiology/labs, pathogen if identified, inpatient therapies and response, discharge medications with durations, pending tests, follow-up appointments, and return precautions.

Draft a discharge summary for myocardial infarction managed with PCI and drug-eluting stent placement; include cath findings, complications, inpatient course, discharge medications (DAPT, statin, beta-blocker, ACEi/ARB), cardiac rehab referral, and follow-up plan.

Draft discharge instructions for a patient hospitalized with acute decompensated heart failure; include daily weights, sodium and fluid restriction amounts, medication list with dosing, signs of worsening heart failure, follow-up appointments, and lab monitoring plan.

Draft discharge instructions for an asthma exacerbation; include controller and reliever regimen, steroid taper schedule, spacer technique, trigger avoidance, a written asthma action plan, return precautions, and follow-up timing.

Draft a patient handout on managing high blood pressure in plain language; explain what BP numbers mean, key lifestyle steps (DASH diet, sodium limits, alcohol moderation), home BP monitoring instructions, medication adherence tips, and when to call the doctor.

Draft a patient handout for type 2 diabetes education in plain language; cover A1c goals, the plate method, physical activity targets, self-monitoring of blood glucose, hypoglycemia signs and the 15-15 rule, foot care basics, and a vaccination checklist.

Draft a summary of the latest CDC and WHO guidelines for managing community-acquired pneumonia in adults, including empiric antibiotic choices, duration of therapy, and follow-up recommendations.

Draft a plain-language overview of the ADA and AACE guidelines for diabetes management, focusing on A1c goals, weight management, and the use of GLP-1 receptor agonists and SGLT2 inhibitors.

Draft a summary of the 2024 USPSTF breast cancer screening recommendations, including updated screening intervals, risk-based approaches, and the role of MRI for high-risk patients.

Draft a concise summary of NCCN guidelines for melanoma management, including staging, surgical margins, adjuvant therapy, and checkpoint inhibitor recommendations.

Draft treatment alternatives for community-acquired MRSA skin infections in patients allergic to sulfa drugs; include oral and IV options, dosing, and duration.

Draft treatment alternatives for patients with type 2 diabetes who are unable to tolerate GLP-1 receptor agonists due to nausea; include medication substitutions and lifestyle recommendations.

Draft a summary of options for treating refractory depression, comparing ketamine infusions, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT).

Draft treatment options for advanced prostate cancer, including hormonal therapy, radiopharmaceuticals, and novel androgen receptor pathway inhibitors.

Draft a summary of recent research on mRNA vaccine technology beyond COVID-19, including applications in oncology and autoimmune disease prevention.

Draft an easy-to-understand overview of long COVID research, summarizing major symptoms, hypothesized mechanisms, and emerging treatment approaches.

Draft a summary of current research on Alzheimer’s disease biomarkers, including amyloid and tau imaging, and discuss how they influence diagnosis and trial design.

Draft an explanation of the interaction between warfarin and antibiotics such as ciprofloxacin or TMP-SMX, including INR effects and management recommendations.

Draft a summary evaluating drug interactions for patients taking Paxlovid and common cardiovascular drugs; include mechanism and recommended dose adjustments.

Draft a summary of the common and serious side effects of semaglutide, including GI intolerance, gallbladder disease, and thyroid-related warnings.

Draft an overview of potential side effects associated with long-term corticosteroid use, including osteoporosis, glucose intolerance, and adrenal suppression.

Draft a summary of essential lab tests to order in suspected acute pancreatitis, including amylase, lipase, liver enzymes, and metabolic panels, with interpretation guidance.

Draft laboratory workup recommendations for suspected hypothyroidism, including TSH, free T4, thyroid antibodies, and when to consider secondary causes.

Draft an explanation of which labs should be monitored in patients receiving methotrexate therapy, including CBC, LFTs, renal function, and frequency of monitoring.

why choose us

Edit Geo

×

300×250 Ad Slot

Research Article: Rim enhancement on MRI predicts long-term outcomes in extruded/migrated lumbar disc herniation managed with an inflammation-preserving protocol: a 6-year prospective cohort study

Date Published: 2026-06-04

Abstract:
Based on the theory of resorption of herniated nucleus pulposus (HNP), this study aimed to investigate the long-term clinical and radiological outcomes of patients with extruded/migrated LDH treated with an inflammation-preserving protocol, and to evaluate the prognostic value of the rim enhancement sign in predicting HNP resorption and clinical efficacy over 6 years. A prospective single-arm cohort study was designed, enrolling 66 patients with extruded or migrated LDH treated at our hospital between January 2016 and September 2019, with follow-up extending to 6 years. All patients received standardized conservative treatment combined with an inflammation-preserving protocol centered on avoidance of non-steroidal anti-inflammatory drugs. Based on the presence of a high-signal rim enhancement of the herniated nucleus pulposus on pre-treatment lumbar contrast-enhanced MRI, patients were divided into a Rim Enhancement Positive group and a Rim Enhancement Negative control group. The herniation volume was dynamically measured via MRI, and the resorption rate was calculated. Clinical outcomes were comprehensively evaluated using baseline data, Japanese Orthopedic Association (JOA) scores, Oswestry Disability Index (ODI), and the positive angle of the Straight Leg Raising Test (SLRT). All 66 patients completed the 6-year follow-up. The mean age was 35.91 ± 10.07 years, with 48 males and 18 females. No statistically significant differences were found in baseline characteristics such as age, gender, and disease duration between the two groups ( P > 0.05). Statistically significant differences were found between the groups regarding herniation volume and overall resorption rate at 1 year and 3 years post-treatment ( P < 0.05). The improvement rates of JOA scores, ODI, SLRT positive angle, and the absolute values of these outcomes at 6 years showed statistically significant differences between the groups ( P < 0.05), while no significant differences were found for other indicators. Within all patients, comparisons of JOA scores, ODI, SLRT positive angle, and herniation volume between pre-treatment and all post-treatment time points revealed statistically significant differences ( P < 0.05). Correlation analysis demonstrated a significant positive correlation between the improvement rate of JOA scores and the resorption rate ( r = 0.614, P < 0.05), a significant positive correlation between the ODI improvement rate and the resorption rate ( r = 0.773, P < 0.05), and a significant positive correlation between the SLRT positive angle improvement rate and the resorption rate ( r = 0.360, P < 0.05). Multivariate linear regression analysis, adjusting for age, gender, symptom duration, and baseline herniation volume, revealed that baseline herniation volume was the strongest independent predictor of JOA improvement rate ( B = 0.035, P < 0.001), while rim enhancement showed a trend toward independent predictive value ( B = 0.156, P = 0.092). All patients showed significant clinical improvement after treatment, with no occurrences of progressive neurological deficit or cauda equina syndrome during the follow-up period. In patients with extruded and migrated LDH managed with an inflammation-preserving protocol, favorable long-term outcomes were observed, with rim enhancement serving as a useful prognostic indicator for nucleus pulposus resorption and symptomatic improvement. However, due to the single-arm design, the specific contribution of inflammation preservation requires validation in future controlled trials.

Introduction:
Low back pain (LBP) is a leading global cause of pain and disability. Lumbar disc herniation (LDH), a common degenerative spinal disorder in adults, is a significant etiology of LBP. Among LDH subtypes, extruded/migrated LDH, where the nucleus pulposus breaches the annulus fibrosus and even the posterior longitudinal ligament, readily causes nerve root compression and severely impacts quality of life ( 1 , 2 ). Conservative treatment is the consensus first-line management for LDH, with approximately 60%?90% of…

Read more

300×250 Ad Slot

×
Chat & Ask Questions Career Openings Medical Doctors Check on Drug
Interactions Latest Health News
by WebHealthNetwork Get CME Credits Latest Clinical Trials Latest Research Articles Clinical Documents Update Profile

News

Chat

HCP Tools

Careers

Update Profile